Ftse Mib
36.719,35
0,00%
DAX
21.505,70
0,47%
S&P 500
6.037,88
0,72%
NASDAQ
19.654,02
1,35%
Bitcoin
97.729,50
-0,13%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Fennec Pharmaceuticals Inc (FENC) Fennec Pharmaceuticals Inc (FENC) Notizie

Fennec Pharmaceuticals Inc

FENC
6,65
0,15 (2,31%)
05 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/2/202523:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202523:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:19EDGAR2Form 144 - Report of proposed sale of securities
03/1/202523:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202523:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202422:37EDGAR2Form 8-K - Current report
20/12/202422:36EDGAR2Form 8-K - Current report
20/12/202412:16GLOBEFennec Pharmaceuticals Announces Pedmarqsi® Positive..
19/12/202412:13GLOBEFennec Pharmaceuticals Announces Early Partial Repayment of..
12/12/202413:01GLOBEFennec Pharmaceuticals to Participate in Upcoming Investor..
05/12/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202422:00EDGAR2Form 144 - Report of proposed sale of securities
04/12/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202422:03EDGAR2Form 144 - Report of proposed sale of securities
03/12/202401:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202419:58EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
13/11/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202412:27GLOBEFennec Pharmaceuticals to Participate in Upcoming Investor..
13/11/202401:38EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
08/11/202422:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202412:13GLOBEFennec Pharmaceuticals Reports Third Quarter 2024 Financial..
04/11/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202422:02EDGAR2Form 144 - Report of proposed sale of securities
31/10/202411:23GLOBEFennec Pharmaceuticals to Report Third Quarter 2024..
30/10/202412:00EDGAR2Form 8-K - Current report
28/10/202411:23GLOBEFennec Pharmaceuticals Strengthens Executive Leadership Team..
01/10/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202422:07EDGAR2Form 144 - Report of proposed sale of securities
05/9/202423:02EDGAR2Form 144 - Report of proposed sale of securities
05/9/202412:56GLOBEFennec Pharmaceuticals to Participate in Upcoming Investor..
05/9/202400:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202400:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202422:05EDGAR2Form 144 - Report of proposed sale of securities
26/8/202423:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/8/202400:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202423:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202412:05GLOBEFennec Pharmaceuticals Reports Second Quarter 2024 Financial..
06/8/202422:31GLOBEFennec Pharmaceuticals to Report Second Quarter 2024..
05/8/202412:26GLOBEFennec Pharmaceuticals Appoints Jeffrey S. Hackman as Chief..
01/8/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202422:21EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 6,50 Min: 6,50 Max: 6,7624
Chiusura: 6,50

La tua Cronologia

NASDAQ
FENC
Fennec Pharmaceuticals
COIN
CAKEUSD
PancakeSwap Token
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci